Navigation Links
Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients
Date:4/7/2009

Sustained Benefits for Patients Awaiting Transplantation

ANN ARBOR, Mich., April 7 /PRNewswire/ -- The DuraHeart(TM) Left Ventricular Assist System (LVAS) shows sustained benefits in providing safe and reliable long-term circulatory support with an improved survival rate and an acceptable adverse event rate in advanced heart failure patients who were eligible for transplantation. These conclusions, based on the European experience with DuraHeart, the first active magnetically levitated centrifugal left ventricular assist system, are published on line in the European Journal of Cardio-thoracic Surgery (EJCTS) at http://dx.doi.org/10.1016/j.ejcts.2008.12.033.

The European experience includes 68 patients who received the DuraHeart Left Ventricular Assist System between January 2004 and July 2008 including 33 patients treated as part of the European multi-center clinical trial (Germany, Austria, and France) and 35 patients treated in the post-trial period. All patients were classified with end-stage heart failure and were on approved lists to receive donor hearts (Bridge to Transplant). The trial sponsor was Terumo Heart, Inc., maker of the DuraHeart System and a wholly owned subsidiary of Terumo Corporation.

"In a patient population with advanced disease at imminent risk of death due to end-stage left ventricular failure and eligible for heart transplantation, the DuraHeart was safe and performed as intended," said Michiel Morshuis, M.D. Senior Physician, Clinic for Thoracic and Cardiovascular Surgery at the Heart and Diabetes Center North Rhine-Westphalia in Bad Oeynhausen. "We believe the device may have potential for long-term circulatory support not only as a bridge to transplant, but also for destination therapy."

Overall, the mean
'/>"/>

SOURCE Terumo Heart, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
2. Study Confirms: Your Hidden Food Allergies Are Making You Fat
3. Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment
4. Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
5. Major Restless Legs Study Completes Enrollment With Support From MediciGlobal
6. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
7. QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy
8. New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery
9. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
10. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
11. First Human Study to Show Sun Chlorella A Supports Heart Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... BURLINGTON, Mass. , May 21, 2013 ... leading research and advisory firms for pharmaceutical ... of an emerging agent on key efficacy ... disease progression, has the most influence over ... for advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast ...
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
(Date:5/21/2013)... 21, 2013  The North Shore-LIJ Health System is ... hand-washing compliance at North Shore University Hospital in ... operating rooms at Forest Hills ... The new pilot program strengthens patient safety by ... (ORs), the first time in the US that remote ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... June 1, 2011 Mirixa Corporation is pleased to ... licensing agreement for MirixaEdge(SM), a clinical application that supports ... Medication Therapy Management (MTM). Family Physicians Group (FPG), ... Source Pharmacy and selected it as FPG,s preferred pharmacy ...
... YORK, June 1, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0305172/Global-Intravenous-IV-Iron-Drugs-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... Intravenous (IV) Iron Drugs in US$ Million. ...
Cached Medicine Technology:MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 2MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 3Global Intravenous (IV) Iron Drugs Industry 2Global Intravenous (IV) Iron Drugs Industry 3Global Intravenous (IV) Iron Drugs Industry 4Global Intravenous (IV) Iron Drugs Industry 5Global Intravenous (IV) Iron Drugs Industry 6Global Intravenous (IV) Iron Drugs Industry 7
(Date:5/21/2013)... May 2013 EMBO announced today that 52 outstanding ... its membership. Forty-three of the researchers reside in Europe ... of nine Associate Members from Canada, China, India, Japan ... around 1600 life scientists. , "Our members are the ... Director Maria Leptin said. "We have been building our ...
(Date:5/21/2013)... GA (PRWEB) May 21, 2013 ... ScripNet and Procura Management, today announced that it ... at Catamaran’s client advisory meeting. Conferred annually, ... partnered with Catamaran to create cutting edge programs ... year, Healthcare Solutions was recognized for its clinical ...
(Date:5/21/2013)... New York, NY (PRWEB) May 21, 2013 ... leukemia, melanoma or non-small cell lung cancer reported that ... behavior in their medicine use, according to new findings ... (NHWS), conducted by Kantar Health . The research ... Meeting for ISPOR (International Society for Pharmacoeconomics and Outcomes ...
(Date:5/21/2013)... A plastic surgery Internet marketing ... surgery SEO services following an Internet survey. , ... the “Best Plastic Surgery SEO Services”. , Sources ... predictable. Well-known in the plastic surgery Internet marketing ... any other selection based on superior client results. ...
(Date:5/21/2013)... It’s nearly summer and millions of kids will soon be ... or fall sports. In many cases a physical exam ... , To help parents during this busy time, MedSpring is ... physicals at just $29. As part of the ... perform a physical exam and complete required forms. Patients can ...
Breaking Medicine News(10 mins):Health News:EMBO announces 52 new members for 2013 2Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2
... of his other colleagues in the industry with his huge list ... his tour of Europe. ,A source said that ... the tablets are quite difficult to get in Europe. ... are difficult to get in Europe," the Sun quoted the source, ...
... to a new review of studies,doctors are famous for ... of medication errors each year. Electronics to the ... entry systems saw a 66 percent drop in prescription ... are responsible for as much as 61 percent of ...
... Gullotta, said today that the review of childrens television standards by ... a ban on junk food advertising in childrens TV viewing times. ... to the ACMA review and he urged all groups concerned with ... ban on junk food advertising to kids must be a priority ...
... version of a molecule found in the egg cells of ... with the first drug treatment for brain tumours. ... tumour cell and binds to its surface before invading the ... to die. ,In new research published in the ...
... has found that fishes use the threat of punishment ... line and the social order stable. ,Their ... humans, has been hailed by some of the worlds leading ... the Proceedings of the Royal Society of London Series B. ...
... and soft drinks, may seem like harmless snacks and beverages, ... permanent damage to teeth. ,Its known as ... the effect of acid on the teeth that leads to ... of tooth erosion are fundamental to keeping teeth healthy for ...
Cached Medicine News:Health News:Computerized Doctors Order Reduce Prescription Errors 2Health News:Computerized Doctors Order Reduce Prescription Errors 3Health News:Brain Tumor Drug in Frogs A New Report 2Health News:Fishes Use Threat of Punishment in Mating Process 2Health News:Too Much of Acidic Foods can Cause Permanent Damage to Teeth 2
Open blade design with aspiration capabilities for removing fluids from the operative site....
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm....
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 15 mm....
Replacement snares for the E3525. 3 per package....
Medicine Products: